News and Announcements
BioProspect and Bio-Gene Technology Sign Agreement
- Published January 21, 2012 2:33PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Natural compound specialists, BioProspect, has signed an agreement with Western Australian private biotech, Bio-Gene Technology, handing over exclusive worldwide rights to natural insecticide, Qcide.
The deal involves four $200,000 fees paid annually to BioProspect and the University of Western Sydney as well as royalties of 4 per cent for the first $1 million in commercialisation income and 2 per cent on additional income over $1 million.
To view the full article, please click the link below.